PDCD1 and lung cancer: We further demonstrate that DNT cell therapy can inhibit the growth of late-stage established lung cancers in xenograft models and that addition of anti-PD-1 therapy further augments DNT cell-mediated anti-tumor function and increases their infiltration into tumor xenografts.